Molnupiravir Outpatient Treatment for Adults with COVID-19 in a Real-World Setting—A Single Center Experience

Molnupiravir Outpatient Treatment for Adults with COVID-19 in a Real-World Setting—A Single Center Experience

Background: Molnupiravir is approved for the treatment of adult patients with mild to moderate COVID-19. The main goal of the treatment is to reduce hospitalization and mortality rate. This study aimed at the all-cause hospitalization and all-cause death assessment in patients at high risk of severe...

Full description

Bibliographic Details
Main Authors: Kinga Czarnecka, Paulina Czarnecka, Olga Tronina, Magdalena Durlik
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Journal of Clinical Medicine
Subjects:
molnupiravir
COVID-19
chronic kidney disease
renal transplant
Online Access:https://www.mdpi.com/2077-0383/11/21/6464

Similar Items

Similar Items